UPDATED Aug 15, 2022
Explore the Hong Kong (HSI) Biggest Losers Today. These Pharmaceuticals & Biotech Stocks have seen the largest drop in Market Cap from the previous trading day.
| Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 570China Traditional Chinese Medicine Holdings | HK$3.19 | -0.3% | -23.1% | HK$16.1b | HK$4.74 | PE7.1x | E7.3% | 4.4% | ||
| 1061Essex Bio-Technology | HK$3.44 | -2.6% | -48.7% | HK$2.0b | HK$7.00 | PE5.7x | E21.1% | 3.2% | ||
| 2257Sirnaomics | HK$61.05 | -0.9% | n/a | HK$5.4b | HK$118.35 | PB3.3x | E10.1% | n/a | ||
| 1167Jacobio Pharmaceuticals Group | HK$4.60 | -1.3% | -73.7% | HK$3.5b | HK$14.28 | PS20x | E-18.8% | n/a | ||
| 1666Tong Ren Tang Technologies | HK$5.07 | -0.6% | -10.4% | HK$6.5b | HK$7.69 | PE11x | E6.4% | 3.7% | ||
| 3613Beijing Tong Ren Tang Chinese Medicine | HK$9.53 | -0.4% | -15.7% | HK$8.0b | HK$14.60 | PE14.4x | E12.6% | 2.9% | ||
| 1681Consun Pharmaceutical Group | HK$4.04 | -1.0% | -15.8% | HK$3.2b | HK$9.00 | PE4.6x | E10.3% | 7.0% | ||
| 690Uni-Bio Science Group | HK$0.075 | -6.3% | -26.5% | HK$477.4m | n/a | PS1.4x | n/a | n/a | ||
| 858Extrawell Pharmaceutical Holdings | HK$0.083 | -11.7% | -23.1% | HK$198.4m | n/a | PE1.5x | n/a | n/a | ||
| 950Lee's Pharmaceutical Holdings | HK$1.86 | -2.1% | -54.9% | HK$1.1b | HK$2.10 | PE0.6x | S8.7% | 3.3% | ||
| 1672Ascletis Pharma | HK$3.50 | -0.6% | 24.6% | HK$3.8b | HK$2.37 | PS42.6x | E97.3% | n/a | ||
| 2633Jacobson Pharma | HK$0.80 | -1.2% | 27.0% | HK$1.5b | n/a | PE8.6x | n/a | 4.8% | ||
| 3933United Laboratories International Holdings | HK$4.04 | -0.2% | -24.8% | HK$7.3b | HK$5.45 | PE6.4x | E6.5% | 4.6% | ||
| 6628Transcenta Holding | HK$3.72 | -0.8% | n/a | HK$1.7b | HK$10.60 | PS28.4x | E31.7% | n/a | ||
| 455Tianda Pharmaceuticals | HK$0.18 | -2.7% | -4.3% | HK$387.0m | n/a | PB0.5x | n/a | 1.4% | ||
| 6978Immunotech Biopharm | HK$4.28 | -0.5% | -74.0% | HK$2.2b | n/a | PB2.3x | n/a | n/a | ||
| 3737Zhongzhi Pharmaceutical Holdings | HK$0.82 | -1.2% | -39.3% | HK$708.2m | n/a | PE11.7x | n/a | 0% | ||
| 1652Fusen Pharmaceutical | HK$0.93 | -1.1% | -62.7% | HK$705.3m | n/a | PE36.5x | n/a | 1.1% | ||
| 1011China NT Pharma Group | HK$0.12 | -3.1% | 24.0% | HK$236.2m | n/a | PE-1.4x | n/a | 0% | ||
| 6118Austar Lifesciences | HK$2.37 | -0.4% | -87.0% | HK$1.2b | n/a | PE3.8x | n/a | 0% | ||
| 8247Biosino Bio-Technology and Science Incorporation | HK$1.33 | -2.2% | 5.6% | HK$192.5m | n/a | PB0.8x | n/a | 0% | ||
| 2616CStone Pharmaceuticals | HK$4.02 | 0% | -70.2% | HK$4.7b | HK$8.87 | PS16.7x | E78.4% | n/a | ||
| 9969InnoCare Pharma | HK$12.18 | 0% | -47.2% | HK$21.5b | HK$21.31 | PS17.7x | E46.6% | n/a | ||
| 8225China Health Group | HK$0.31 | 0% | -20.5% | HK$308.6m | n/a | PE9x | n/a | n/a |